Pegbio

Developer of therapeutic solutions for treating type II diabetes and rheumatoid arthritis

placeSuzhou, Jiangsu, China calendar_todayFounded 2007 groups53 employees language pegbio.com

Innovation

8 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 244 times.

YearFilings
20121
20131
20153
20172
20181
20191
20202
20212
20221
20232
20243
20251

Investor mix

8 investors on record.

Investor typeCountShare
Venture capital563%
Private equity225%
Other / undisclosed113%
Coming soon